Addyi for Acquired, Generalized HSDD

Addyi is the brand name for flibanserin 100 mg, a prescription medicine for acquired, generalized hypoactive sexual desire disorder in premenopausal women when low desire causes marked distress or interpersonal difficulty. Flibanserin acts in the central nervous system at serotonin receptors and changes dopamine, norepinephrine, and serotonin signalling; it is taken every night rather than immediately before sexual activity.

• Indication: acquired, generalized HSDD in premenopausal women, after a clinician has assessed other possible causes of low desire.
• Usual regimen: 100 mg by mouth once daily at bedtime.
• Stop and review: discontinue after eight weeks if there is no improvement.
• Never use: with moderate or severe liver impairment, or with a strong or moderate CYP3A4 inhibitor unless the prescriber specifically manages the interaction.

What is Addyi and how does flibanserin work?

Addyi contains flibanserin, a centrally acting serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist. It is believed to modify neurotransmitter balance in brain areas involved in sexual desire, increasing dopamine and norepinephrine and decreasing serotonin in the prefrontal cortex. It is not a hormone, a PDE5 inhibitor, or a medicine for immediate sexual performance. Its clinical use is limited to the indicated HSDD population.

Only buy Addyi after a clinician has diagnosed acquired, generalized HSDD and reviewed medicines, alcohol use, liver health, and low-blood-pressure risk. Addyi price can differ by pharmacy, pack size, insurance coverage, and any available pharmacy-discount program.

Who can use Addyi for low sexual desire?

HSDD involves persistently or recurrently low sexual desire that causes significant distress and is not better explained by a medical or psychiatric condition, relationship difficulty, another medicine, or substance use. Addyi is not indicated for men, children, or postmenopausal women. It is not intended for low desire caused solely by pain with intercourse, a new relationship problem, untreated depression, medication adverse effects, or a medical illness; those causes require their own assessment and care.

What is the Addyi dosage and how is it taken?

Take Addyi 100 mg once daily at bedtime, exactly as prescribed. Bedtime dosing is important because flibanserin can cause sleepiness, dizziness, and low blood pressure. Do not take it in the morning, do not take more than one dose in a day, and do not use an extra tablet before sex. Take it regularly for the trial period prescribed, then reassess benefit. If symptoms have not improved after eight weeks, treatment should be stopped.

Patients who buy Addyi 100 mg should use only the bedtime regimen on the prescription label. The Addyi price for the prescribed supply should be confirmed before dispensing rather than changing the quantity or source without pharmacist input.

What should happen after a missed Addyi dose?

Skip a missed bedtime dose and take the next dose at the usual bedtime the following day. Do not take the missed tablet the next morning and do not double the dose. Taking flibanserin at an unintended time may increase the risk of low blood pressure, fainting, dizziness, and accidental injury.

What are the most common side effects of Addyi?

Dizziness, sleepiness, nausea, fatigue, insomnia, dry mouth, and low blood pressure can occur. The most important immediate safety concern is syncope or severe hypotension, especially when flibanserin is combined with alcohol, interacting medicines, or taken other than at bedtime. Do not drive, use machinery, or do activities requiring full alertness for at least six hours after a dose and until the personal response is known.

Seek urgent medical care for fainting, severe lightheadedness, a fall, chest discomfort, confusion, or symptoms of a serious allergic reaction such as facial swelling, hives, wheezing, or difficulty breathing. Tell the clinician about depression, anxiety, substance-use history, and any new mood or behavioral symptoms.

What are the long-term side effects of Addyi?

Longer-term treatment should be reviewed for meaningful improvement in desire and distress, ongoing dizziness or fatigue, blood-pressure symptoms, sleep effects, alcohol habits, and changes to the medicine list. It should not be continued automatically if there is no clear benefit. A clinician may also reassess relationship factors, mental health, hormonal status, pain, and concurrent medicines because these can influence sexual desire over time.

Which medicines interact with Addyi?

Flibanserin has clinically important CYP3A4 interactions. Strong or moderate inhibitors can substantially raise flibanserin levels and increase hypotension and syncope risk; examples include ketoconazole, itraconazole, fluconazole, clarithromycin, erythromycin, ciprofloxacin, diltiazem, verapamil, nefazodone, and certain HIV antivirals. CYP3A4 inducers, including rifampin, carbamazepine, phenytoin, and St. John’s wort, can reduce effectiveness. Sedatives, opioid pain medicines, anxiety medicines, sleep medicines, and other drugs that lower blood pressure can add to drowsiness or dizziness.

How does Addyi interact with alcohol?

Alcohol can increase the risk of low blood pressure, fainting, and injury. Follow the current product instructions and the prescriber’s specific guidance: drinking close to a bedtime dose may require skipping that dose, and alcohol should not be used with the medicine without understanding the timing restrictions. Never take flibanserin with alcohol if a clinician has instructed complete avoidance, and seek help after fainting or severe dizziness.

Is Addyi safe during pregnancy or breastfeeding?

Tell the prescriber before treatment if pregnancy is planned, suspected, or confirmed, and discuss breastfeeding. The appropriate decision requires an individual review of potential risks, benefits, and available alternatives. Do not start, stop, or resume treatment during pregnancy or while breastfeeding without professional guidance.

Who should not take Addyi?

Addyi is contraindicated with moderate or severe hepatic impairment, because impaired metabolism can raise drug exposure. It is also contraindicated with moderate or strong CYP3A4 inhibitors and after a prior hypersensitivity reaction. Give the clinician a full list of medicines and supplements, including herbal products and grapefruit-containing products, before starting therapy.

What should be done in an Addyi overdose?

Too much flibanserin can cause pronounced drowsiness, dizziness, low blood pressure, fainting, and nausea. Contact emergency services or a poison-control resource promptly after an overdose, especially if the person collapses, cannot stay awake, or is injured. Keep the medicine package available for identification.

How should Addyi be stored and obtained?

Store tablets at room temperature in the original container, protected from excess heat and moisture and out of reach of children. If deciding where to buy Addyi, use a licensed pharmacy and ensure that current counselling on alcohol and drug interactions is provided. Patients who buy Addyi should confirm that their medicine list has been reviewed for new interactions. The final Addyi price depends on the prescription quantity and coverage.

This information is general and does not replace individualized diagnosis, prescribing, or urgent medical care.